3
Announcements
Trials
Browse
Landscape
Status
Completed
83
Terminated
26
Withdrawn
7
Recruiting
5
Unknown
4
Active not recruiting
3
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
65
Lymphoma
59
Lymphoma, Follicular
53
Lymphoma, Large B-Cell, Diffuse
51
Lymphoma, B-Cell
50
Leukemia, Lymphocytic, Chronic, B-Cell
34
Lymphoma, Non-Hodgkin
33
Recurrence
27
Leukemia
22
Lymphoma, Mantle-Cell
20
Burkitt Lymphoma
18
Lymphoma, T-Cell, Peripheral
17
Leukemia, Myeloid, Acute
15
Hodgkin Disease
15
Waldenstrom Macroglobulinemia
14
Hematologic Neoplasms
14
Lymphoma, B-Cell, Marginal Zone
13
Multiple Myeloma
12
Lymphoma, T-Cell, Cutaneous
12
Lymphoma, Extranodal NK-T-Cell
12
Neoplasms
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, B-Cell
8
Motor Activity
7
Myelodysplastic Syndromes
6
Mycosis Fungoides
6
Sezary Syndrome
5
Neoplasm, Residual
5
Lymphoma, T-Cell
5
Pain
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Myelodysplastic-Myeloproliferative Diseases
×
Lymphoid
×
Clear all
NCT05969821
2026-03-23
CHIS
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
5,000 enrolled